Press Releases

NASHVILLE, Tenn., Sept. 30, 2019 /PRNewswire/ -- On the banks of the Cumberland River, the Nashville skyline provided the perfect backdrop for a snapshot of support for wounded veterans as more than 1,300 people participated in the Wounded Warrior Project® (WWP) Carry Forward® 5K

PARIS, Sept. 30, 2019 /PRNewswire/ -- Data published today in the New England Journal of Medicine showed that patients with metastatic castration-resistant prostate cancer (mCRPC) previously treated with docetaxel and who progressed within 12 months on an androgen receptor (AR)-targeted agent (abiraterone or enzalutamide) experienced significantly longer radi

BRANFORD, Conn., Sept. 30, 2019 /PRNewswire/ -- IsoPlexis, the leader in single-cell functional proteomics, continues to accelerate immunotherapy development with its IsoLight system, which was highlighted in the recent publication, Biomarkers for Immunotherapy of Cancer. The Springer Protocols book outlines emerging standards for cancer immunotherapy

MINNEAPOLIS, Sept. 30, 2019 /PRNewswire/ -- Dr. Stephen McDonnell was installed as president of the Minnesota Dental Association (MDA) for the 201

ALBUQUERQUE, N.M., Sept. 30, 2019 /PRNewswire/ -- Glo, producers of chewable CBD tablets endorsed by professional athletes and charitable organizations focused on helping veterans, announces a major price drop on its Glo Chewables 30 count bottles. The price reduction makes Glo's product line more accessible to budget-minded individuals who use Glo Chewables on an o

SILVER SPRING, Md., Sept. 30, 2019 /PRNewswire/ -- Innovation in medical devices, spurred in many cases by advances in materials sciences, continues to improve the lives of patients. The growing number of available materials used in today's medical devices ‒ such as metal, plastic, silicone, animal-derived products or some combination of these ‒ reflects cont

NEW YORK, Sept. 30, 2019 /PRNewswire/ -- "The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that their drug INVOKANA® (Canagliflozin) has been approved by the U.S. Food and Drug Administration (FDA) to reduce the risk of end-stage kidney disease (ESKD) and cardiovascular events in patients with Type 2 diabetes and chronic kidney disease (C

ORANGE COUNTY, Calif., Sept. 30, 2019 /PRNewswire/ -- First there was television workout with Jack Lalanne. Then VHS/DVD workouts were hot. After that was streaming workouts from YouTube and others. Recently some companies broadcast workouts but receive little or no information back. Now there is WebFitness an interactive

ROCKVILLE, Md., Sept. 30, 2019 /PRNewswire/ -- RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the Company" or "RegeneRx"), a clinical-stage drug development company focused on tissue protection, repair and regeneration, announced today that GtreeBNT, its Korean partner in the U.S. development of RGN-259 for the treatment of dry eye disease, issued an updat

CLEVELAND, Sept. 30, 2019 /PRNewswire/ -- The National Cybersecurity Center of Excellence (NCCoE) at the National Institute of Standards and Technology (NIST) is releasing a new practice guide – NIST Special Publication 1800-24, Securing Picture Archiving and Communication System (PACS) – to help healthcare delivery organizations (HDOs) protect patient